Biotech Industry, Biotech News, Biotechnology Articles Fierce. Biotech. Following poor results from Roche and Astra. Zeneca, Sanofi says it is canning a phase 2 trial in idiopathic pulmonary fibrosis. The data show an uptick in the proportion of patients able to sit unassisted and talk, fueling Ave.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |